Techno Blender
Digitally Yours.

Biogen to Buy Reata in $7.3 Billion Deal

0 114




The deal would bolster the biotech company’s portfolio of treatments for neuromuscular and rare diseases.




The deal would bolster the biotech company’s portfolio of treatments for neuromuscular and rare diseases.

FOLLOW US ON GOOGLE NEWS

Read original article here

Denial of responsibility! Techno Blender is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – [email protected]. The content will be deleted within 24 hours.

Leave a comment